chr12-85979381-T-C
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_001351288.2(MGAT4C):āc.1345A>Gā(p.Ile449Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00115 in 1,612,352 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001351288.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MGAT4C | NM_001351288.2 | c.1345A>G | p.Ile449Val | missense_variant | 5/5 | ENST00000611864.5 | NP_001338217.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MGAT4C | ENST00000611864.5 | c.1345A>G | p.Ile449Val | missense_variant | 5/5 | 5 | NM_001351288.2 | ENSP00000481096 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000922 AC: 140AN: 151904Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.00135 AC: 337AN: 250440Hom.: 3 AF XY: 0.00138 AC XY: 187AN XY: 135412
GnomAD4 exome AF: 0.00118 AC: 1719AN: 1460330Hom.: 4 Cov.: 31 AF XY: 0.00120 AC XY: 870AN XY: 726542
GnomAD4 genome AF: 0.000921 AC: 140AN: 152022Hom.: 1 Cov.: 32 AF XY: 0.000915 AC XY: 68AN XY: 74350
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2022 | The c.1345A>G (p.I449V) alteration is located in exon 7 (coding exon 3) of the MGAT4C gene. This alteration results from a A to G substitution at nucleotide position 1345, causing the isoleucine (I) at amino acid position 449 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2022 | MGAT4C: BP4, BS2 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at